Minister, I believe Ms. Bennett raised this issue earlier, but I'd like to go back to it. You know that, in the Senate, they're discussing a bill on drug exports to the United States. We would be lifting the prohibition from buying drugs in large quantities in Canada. If this legislation were passed and the medications cross the border to meet the demand of Americans—I don't have any figures, but the U.S. market is enormous—that could have serious repercussions for supply and the reserve in Canada and Quebec. That could affect the industry's balance in maintaining the inventory of available medications. You also have to think about expiry dates, production and so on.
That doesn't seem to trouble you. I met with people from your department who said that that scenario wasn't likely, that the exchange rate had fluctuated and that there was now new insurance to reimburse the cost of medications for part of the U.S. population. Apart from all that, if it becomes too attractive for them—medications are much less expensive in Canada—what is your plan to prohibit this practice? Why don't you prohibit it automatically?
Various countries are conducting transactions to buy medications. Why go headlong in this direction and allow citizens and businesses to make wholesale purchases in Canada. What is your action plan? What act could allow you to prohibit this practice overnight, in view of the fact that this is what is happening? It is happening; we mustn't put our heads in the sand. This is a promising market for the Americans, who need drugs. Shouldn't the industry produce more drugs?
Answer that question, minister.